KEWAUNEE SCIENTIFIC CP (KEQU)
US4928541048 - Common Stock
We assign a fundamental rating of 4 out of 10 to KEQU. KEQU was compared to 192 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of KEQU get a neutral evaluation. Nothing too spectacular is happening here. KEQU has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
KEQU had positive earnings in the past year.
In the past year KEQU had a positive cash flow from operations.
In multiple years KEQU reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: KEQU reported negative operating cash flow in multiple years.
1.2 Ratios
KEQU's Return On Assets of 6.91% is amongst the best of the industry. KEQU outperforms 86.46% of its industry peers.
KEQU has a better Return On Equity (19.81%) than 93.75% of its industry peers.
With an excellent Return On Invested Capital value of 13.95%, KEQU belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.91% | ||
| ROE | 19.81% | ||
| ROIC | 13.95% |
ROA(3y)-2.89%
ROA(5y)-2.51%
ROE(3y)-8.07%
ROE(5y)-6.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
KEQU has a better Profit Margin (4.34%) than 74.48% of its industry peers.
KEQU's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.67%, KEQU is in the better half of the industry, outperforming 73.44% of the companies in the same industry.
KEQU's Operating Margin has declined in the last couple of years.
KEQU's Gross Margin of 23.76% is on the low side compared to the rest of the industry. KEQU is outperformed by 78.13% of its industry peers.
KEQU's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | 4.34% | ||
| GM | 23.76% |
OM growth 3YN/A
OM growth 5Y-17.04%
PM growth 3YN/A
PM growth 5Y-37.53%
GM growth 3Y0.74%
GM growth 5Y-4.45%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.
The number of shares outstanding for KEQU remains at a similar level compared to 1 year ago.
Compared to 5 years ago, KEQU has more shares outstanding
The debt/assets ratio for KEQU is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.67 indicates that KEQU is not in any danger for bankruptcy at the moment.
KEQU has a better Altman-Z score (3.67) than 71.35% of its industry peers.
KEQU has a debt to FCF ratio of 2.61. This is a good value and a sign of high solvency as KEQU would need 2.61 years to pay back of all of its debts.
KEQU has a better Debt to FCF ratio (2.61) than 89.06% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that KEQU is somewhat dependend on debt financing.
KEQU has a worse Debt to Equity ratio (0.70) than 72.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | 2.61 | ||
| Altman-Z | 3.67 |
ROIC/WACC1.43
WACC9.74%
2.3 Liquidity
A Current Ratio of 2.28 indicates that KEQU has no problem at all paying its short term obligations.
With a Current ratio value of 2.28, KEQU is not doing good in the industry: 67.71% of the companies in the same industry are doing better.
KEQU has a Quick Ratio of 1.76. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.76, KEQU is not doing good in the industry: 63.02% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.28 | ||
| Quick Ratio | 1.76 |
3. Growth
3.1 Past
KEQU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1334.32%, which is quite impressive.
KEQU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.27% yearly.
KEQU shows a decrease in Revenue. In the last year, the revenue decreased by -6.59%.
The Revenue has been growing slightly by 6.78% on average over the past years.
EPS 1Y (TTM)1334.32%
EPS 3YN/A
EPS 5Y-33.27%
EPS growth Q2Q240.1%
Revenue 1Y (TTM)-6.59%
Revenue growth 3Y14.17%
Revenue growth 5Y6.78%
Revenue growth Q2Q-23.09%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
KEQU is valuated correctly with a Price/Earnings ratio of 12.06.
Based on the Price/Earnings ratio, KEQU is valued cheaply inside the industry as 94.79% of the companies are valued more expensively.
KEQU is valuated cheaply when we compare the Price/Earnings ratio to 24.55, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.06 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 97.40% of the companies listed in the same industry.
98.44% of the companies in the same industry are more expensive than KEQU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.43 | ||
| EV/EBITDA | 6.03 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
KEQU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
KEWAUNEE SCIENTIFIC CP
NASDAQ:KEQU (5/2/2024, 11:18:54 AM)
35.7
-0.4 (-1.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap102.82M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.06 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.91% | ||
| ROE | 19.81% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 7.67% | ||
| PM (TTM) | 4.34% | ||
| GM | 23.76% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.28 | ||
| Quick Ratio | 1.76 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1334.32%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.59%
Revenue growth 3Y14.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y